台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    130.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.76%
  • 成交量
    15
  • 產業
    上櫃 生技醫療類股
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-華南永昌-民權 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-民權 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/035130.5000.00131.0052221.99%
2024/11/113129.5000.00135.5032512.00%
2024/08/1900.002137.00137.00-213-14.87%
2024/08/1200.002136.00136.00-214-14.12%
2024/07/1700.001162.00162.50-111-9.02%
2023/11/082153.0000.00153.0021019.97%
2023/11/022158.5000.00157.002921.05%
2023/09/131164.001165.00165.000140.00%
2023/08/2200.002170.00170.00-224-8.19%
2023/07/0600.001170.50172.00-151-1.95%
2023/06/121168.5000.00171.501531.87%
2023/03/082172.2500.00170.502643.12%
2023/03/0600.002182.75180.00-260-3.33%
2023/02/0300.002162.50159.00-266-3.02%
2023/02/0200.002162.00162.00-266-3.02%
2023/01/1300.001155.50156.00-168-1.46%
2023/01/121153.5000.00155.001681.46%
2022/12/272170.0000.00163.002712.82%
2022/12/264179.002174.75171.002692.88%
2022/10/286138.0000.00134.0061005.94%
2022/10/253138.3300.00136.5031002.98%
2022/08/2600.000175.00174.50089-0.01%
2022/08/220174.0000.00170.000810.01%
2022/05/2500.003126.50126.50-337-7.90%
2020/09/0300.0010123.00123.00-10127-7.85%
2020/02/2000.001113.50116.00-165-1.53%
2020/02/071110.0000.00107.501681.46%
2020/01/203118.5000.00118.503604.97%
2020/01/152117.0000.00117.002613.24%
2019/12/1300.0014115.00115.50-1470-19.93%
2019/12/1200.0012115.08115.50-1269-17.16%
2019/11/221118.5000.00122.501641.55%
2019/11/017126.8600.00127.0076410.90%
2019/10/292125.5000.00124.502692.89%
2019/10/281125.0000.00125.501761.30%
2019/10/257126.3600.00126.507808.65%
2019/10/236124.5800.00124.506827.30%
2019/10/2200.001125.00124.00-183-1.20%
2019/10/211126.5000.00126.501831.20%
2019/10/182126.7500.00126.002862.32%
2019/10/161126.5000.00125.001901.10%
2019/10/152125.5000.00126.002922.17%
2019/08/023146.5000.00150.003963.12%
2019/07/222150.5000.00154.002812.45%
2018/10/2400.00190.0089.50-152-1.89%
2018/10/041101.5000.00100.501521.91%
2018/06/2100.002146.00145.50-2276-0.72%
2018/06/202145.0000.00144.5022770.72%
2018/04/1200.001158.50158.50-1335-0.30%
2018/04/031169.0000.00167.5013150.32%
2018/02/0800.002155.50155.50-2293-0.68%
2018/01/291183.0000.00183.0013250.31%
2018/01/261177.5000.00179.5013210.31%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章